Page last updated: 2024-08-23

nimustine and ganu

nimustine has been researched along with ganu in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaike, Y; Arai, Y; Kawamori, M; Morikawa, T; Ozeki, M; Tsujihara, K1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Kato, T; Ota, K2
Fujimoto, S; Ogawa, M2
Hoshino, A; Machida, S; Nagura, E; Sugihara, T1

Reviews

1 review(s) available for nimustine and ganu

ArticleYear
Current status of nitrosoureas under development in Japan.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1981, Volume: 76

    Topics: Animals; Antineoplastic Agents; Drug Evaluation; Humans; Japan; Neoplasms; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin

1981

Other Studies

6 other study(ies) available for nimustine and ganu

ArticleYear
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:4

    Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Leukemia L1210; Lomustine; Male; Mice; Nitrosourea Compounds

1982
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cytarabine; Fluorouracil; Leukemia L1210; Mice; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Streptozocin; Tegafur; Uracil

1987
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Cancer chemotherapy and pharmacology, 1982, Volume: 9, Issue:3

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin

1982
[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:5

    Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Leukemia L1210; Mice; Nimustine; Nitrosourea Compounds; Solubility; Streptozocin

1983
Combination chemotherapy of L1210 mouse leukemia using a new water-soluble nitrosourea, 1-(2-chloroethyl)-3-(beta-d-glucopyranosyl)-1-nitrosourea, with various antimetabolites.
    Gan, 1980, Volume: 71, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Drug Resistance; Drug Therapy, Combination; Female; Leukemia L1210; Mice; Nimustine; Nitrosourea Compounds; Streptozocin

1980
chemdatabank.com